Trials / Completed

CompletedNCT00002293

A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes

Nystatin Pastille for the Prophylaxis of Oral Candidiasis in Patients With AIDS or AIDS Related Syndromes

Status: Completed
Phase: N/A
Study type: Interventional
Enrollment: —

Sponsor: Bristol-Myers Squibb · Industry
Sex: All
Age: 12 Years
Healthy volunteers: Not accepted

Summary

To determine a safe, effective, and convenient dosing schedule for nystatin pastilles in the prophylaxis of oral candidiasis in patients with AIDS or AIDS related syndromes (group III or IV, CDC classification)

Conditions

Candidiasis, Oral
HIV Infections

Interventions

Type	Name	Description
DRUG	Nystatin

Timeline

First posted: 2001-08-31
Last updated: 2007-10-02

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00002293. Inclusion in this directory is not an endorsement.